Annual Working Capital
$949.51 M
-$414.81 M-30.40%
31 December 2022
Summary:
Mirati Therapeutics annual working capital is currently $949.51 million, with the most recent change of -$414.81 million (-30.40%) on 31 December 2022. During the last 3 years, it has fallen by -$414.81 million (-30.40%).MRTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$898.70 M
+$219.77 M+32.37%
30 September 2023
Summary:
Mirati Therapeutics quarterly working capital is currently $898.70 million, with the most recent change of +$219.77 million (+32.37%) on 30 September 2023.MRTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -30.4% | -34.1% |
| 5 y5 years | +152.9% | +139.3% |
MRTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -30.4% | -34.1% |
Mirati Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $898.70 M(+32.4%) |
| June 2023 | - | $678.93 M(-16.7%) |
| Mar 2023 | - | $814.75 M(-14.2%) |
| Dec 2022 | $949.51 M(-30.4%) | $949.51 M(-13.6%) |
| Sept 2022 | - | $1.10 B(+1.4%) |
| June 2022 | - | $1.08 B(-11.1%) |
| Mar 2022 | - | $1.22 B(-10.6%) |
| Dec 2021 | $1.36 B(+2.4%) | $1.36 B(+30.0%) |
| Sept 2021 | - | $1.05 B(-4.3%) |
| June 2021 | - | $1.10 B(-10.5%) |
| Mar 2021 | - | $1.23 B(-7.9%) |
| Dec 2020 | $1.33 B(+254.8%) | $1.33 B(+152.3%) |
| Sept 2020 | - | $528.02 M(-11.5%) |
| June 2020 | - | $596.34 M(-8.1%) |
| Mar 2020 | - | $648.77 M(+72.8%) |
| Dec 2019 | $375.50 M(+87.3%) | $375.50 M(-12.5%) |
| Sept 2019 | - | $429.31 M(-8.2%) |
| June 2019 | - | $467.50 M(+66.2%) |
| Mar 2019 | - | $281.28 M(+40.3%) |
| Dec 2018 | $200.51 M(+41.1%) | $200.51 M(-10.5%) |
| Sept 2018 | - | $224.16 M(-8.7%) |
| June 2018 | - | $245.47 M(+79.1%) |
| Mar 2018 | - | $137.06 M(-3.6%) |
| Dec 2017 | $142.12 M(+219.0%) | $142.12 M(+115.9%) |
| Sept 2017 | - | $65.82 M(-18.3%) |
| June 2017 | - | $80.54 M(-16.7%) |
| Mar 2017 | - | $96.64 M(+116.9%) |
| Dec 2016 | $44.55 M(-61.5%) | $44.55 M(-27.9%) |
| Sept 2016 | - | $61.83 M(-22.0%) |
| June 2016 | - | $79.25 M(-20.0%) |
| Mar 2016 | - | $99.08 M(-14.3%) |
| Dec 2015 | $115.60 M(+324.1%) | $115.60 M(-11.9%) |
| Sept 2015 | - | $131.27 M(+144.0%) |
| June 2015 | - | $53.80 M(-18.6%) |
| Mar 2015 | - | $66.08 M(+142.4%) |
| Dec 2014 | $27.26 M | $27.26 M(-21.6%) |
| Sept 2014 | - | $34.77 M(+704.6%) |
| June 2014 | - | $4.32 M(-67.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $13.32 M(-47.9%) |
| Dec 2013 | $25.56 M(-24.8%) | $25.56 M(-204.2%) |
| Sept 2013 | - | -$24.54 M(-534.8%) |
| June 2013 | - | $5.64 M(-78.1%) |
| Mar 2013 | - | $25.71 M(-24.3%) |
| Dec 2012 | $33.99 M(+27.8%) | $33.99 M(+129.8%) |
| Sept 2012 | - | $14.79 M(-23.7%) |
| June 2012 | - | $19.40 M(-20.1%) |
| Mar 2012 | - | $24.28 M(-8.7%) |
| Dec 2011 | $26.61 M(+474.6%) | $26.61 M(-9.0%) |
| Sept 2011 | - | $29.25 M(-14.1%) |
| June 2011 | - | $34.03 M(+1921.6%) |
| Mar 2011 | - | $1.68 M(-63.6%) |
| Dec 2010 | $4.63 M(-63.4%) | $4.63 M(-30.2%) |
| Sept 2010 | - | $6.63 M(-39.3%) |
| June 2010 | - | $10.93 M(+19.0%) |
| Mar 2010 | - | $9.18 M(-27.4%) |
| Dec 2009 | $12.64 M(-57.2%) | $12.64 M(-22.3%) |
| Sept 2009 | - | $16.28 M(-17.8%) |
| June 2009 | - | $19.80 M(-16.0%) |
| Mar 2009 | - | $23.58 M(-20.2%) |
| Dec 2008 | $29.53 M(-46.7%) | $29.53 M(+9.5%) |
| Sept 2008 | - | $26.96 M(-36.0%) |
| June 2008 | - | $42.12 M(-15.1%) |
| Mar 2008 | - | $49.60 M(-10.5%) |
| Dec 2007 | $55.45 M(+5.4%) | $55.45 M(-11.2%) |
| Sept 2007 | - | $62.44 M(-3.3%) |
| June 2007 | - | $64.59 M(-1.6%) |
| Mar 2007 | - | $65.66 M(+24.8%) |
| Dec 2006 | $52.61 M(+152.0%) | $52.61 M(-8.8%) |
| Sept 2006 | - | $57.67 M(+3.1%) |
| June 2006 | - | $55.93 M(+46.4%) |
| Mar 2006 | - | $38.20 M(+82.9%) |
| Dec 2005 | $20.88 M(-35.8%) | $20.88 M(-15.8%) |
| Sept 2005 | - | $24.81 M(-6.8%) |
| June 2005 | - | $26.63 M(-12.4%) |
| Mar 2005 | - | $30.39 M |
| Dec 2004 | $32.51 M(+41.0%) | - |
| Dec 2003 | $23.07 M | - |
FAQ
- What is Mirati Therapeutics annual working capital?
- What is the all time high annual working capital for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Mirati Therapeutics?
What is Mirati Therapeutics annual working capital?
The current annual working capital of MRTX is $949.51 M
What is the all time high annual working capital for Mirati Therapeutics?
Mirati Therapeutics all-time high annual working capital is $1.36 B
What is Mirati Therapeutics quarterly working capital?
The current quarterly working capital of MRTX is $898.70 M
What is the all time high quarterly working capital for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly working capital is $1.36 B